Zubair H Aghai Selected Research

Zubair H Aghai Research Topics

Disease

10	Bronchopulmonary Dysplasia 11/2019 - 10/2007
6	Birth Weight (Birth Weights) 02/2022 - 01/2002
6	Chorioamnionitis 01/2021 - 08/2012
5	Hyperoxia 01/2021 - 05/2011
4	Neonatal Abstinence Syndrome 03/2022 - 01/2019
4	Sepsis (Septicemia) 02/2022 - 01/2018
2	COVID-19 02/2022 - 12/2021
2	Apnea 02/2022 - 06/2012
2	Human Influenza (Influenza) 02/2022 - 12/2021
2	Necrotizing Enterocolitis 03/2021 - 05/2012
2	Pneumonia (Pneumonitis) 01/2021 - 10/2007
2	Neonatal Sepsis 01/2020 - 06/2014
2	Gastroesophageal Reflux (GERD) 01/2018 - 05/2013
2	Hemorrhage 01/2016 - 11/2014
2	Patent Ductus Arteriosus 01/2016 - 11/2014
2	Acute Lung Injury 01/2013 - 06/2006
1	Hypoglycemia (Reactive Hypoglycemia) 02/2022
1	Coronavirus Infections 02/2022
1	Hyperbilirubinemia 02/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021
1	alpha-Thalassemia 12/2020
1	Lung Injury 11/2019
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2019
1	Infections 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 07/2017
1	Sudden Infant Death (SID) 06/2012
1	Pulmonary Hypertension 05/2012
1	Rickettsia Infections 11/2011
1	Cholestasis 08/2011
1	Invasive Candidiasis 08/2011
1	Invasive Fungal Infections 08/2011
1	Emphysema 05/2011
1	Autoimmune Hypothyroidism 10/2009
1	Congenital Hypothyroidism (Cretinism) 10/2009
1	Seizures (Absence Seizure) 10/2009
1	Newborn Respiratory Distress Syndrome 01/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2006

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2018
4	nasIBA 03/2022 - 01/2019
3	Oxygen (Dioxygen)IBA 01/2016 - 02/2008
2	EpitopesIBA 02/2022 - 12/2021
2	AntigensIBA 02/2022 - 12/2021
2	Caffeine (No Doz)FDA LinkGeneric 02/2022 - 11/2014
2	Nucleocapsid ProteinsIBA 02/2022 - 12/2021
2	Immunoglobulin G (IgG)IBA 02/2022 - 12/2021
2	Immunoglobulin M (IgM)IBA 02/2022 - 11/2011
2	MicroRNAs (MicroRNA)IBA 11/2019 - 10/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2002
2	Angiopoietin-1IBA 10/2017 - 05/2011
2	Pepsin A (Pepsin)IBA 05/2013 - 02/2008
2	Dexamethasone (Maxidex)FDA LinkGeneric 08/2012 - 06/2006
2	NF-kappa B (NF-kB)IBA 10/2007 - 06/2006
1	Hemagglutinins (Hemagglutinin)IBA 02/2022
1	AntibodiesIBA 02/2022
1	Pharmaceutical PreparationsIBA 02/2022
1	Methadone (Dolophine)FDA LinkGeneric 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	antiarrhythmic peptide (AAP)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	IronIBA 12/2020
1	Caveolin 1IBA 11/2019
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	AcidsIBA 01/2018
1	Pepsinogen A (Pepsinogen)IBA 05/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Interferon-gamma (Interferon, gamma)IBA 01/2013
1	InterferonsIBA 01/2013
1	CytokinesIBA 08/2012
1	Sirtuin 1IBA 08/2012
1	Histones (Histone)IBA 08/2012
1	XanthineIBA 06/2012
1	SmokeIBA 06/2012
1	XanthinesIBA 06/2012
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2012
1	Lysine (L-Lysine)FDA Link 05/2012
1	Ibuprofen (Motrin)FDA LinkGeneric 05/2012
1	Fluconazole (Zonal)FDA LinkGeneric 08/2011
1	Angiopoietin-2IBA 05/2011
1	Messenger RNA (mRNA)IBA 05/2011
1	Cyclin-Dependent Kinase Inhibitor p21IBA 05/2011
1	CaspasesIBA 05/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2011
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2011
1	Macrophage Migration-Inhibitory FactorsIBA 01/2008
1	SteroidsIBA 10/2007
1	Inflammation MediatorsIBA 06/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2007
3	Artificial Respiration (Mechanical Ventilation) 07/2017 - 11/2015
3	Continuous Positive Airway Pressure 06/2016 - 09/2006
1	Length of Stay 03/2021
1	Induced Hypothermia 01/2019
1	Enteral Nutrition (Feeding, Tube) 01/2018
1	Mechanical Ventilators (Ventilator) 07/2017
1	Extracorporeal Membrane Oxygenation 07/2017
1	Cannula 06/2016
1	Ligation 01/2016
1	Intermittent Positive-Pressure Ventilation 09/2006
1	Critical Care (Surgical Intensive Care) 01/2002